Showing results (221-230 of 233) with videos related to
Sort By:
Pageof 24
Gut|February 23, 2011
The role of apolipoprotein A5 in non-alcoholic fatty liver diseaseC Ress, A R Moschen, N Sausgruber, et al.The American Journal of Pathology|April 26, 2011
A murine model of phosphate nephropathyPhilipp Eller, Kathrin Eller, Alexander H Kirsch, et al.Atherosclerosis|April 13, 2012
Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbitsEgon Demetz, Ivan Tancevski, Kristina Duwensee, et al.Atherosclerosis|August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer proteinKristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.European Journal of Pharmacology|October 7, 2008
Monocyte migration: a novel effect and signaling pathways of catestatinMargot Egger, Arno G E Beer, Markus Theurl, et al.Journal of Lipid Research|December 25, 2008
The thyromimetic T-0681 protects from atherosclerosisIvan Tancevski, Andreas Wehinger, Egon Demetz, et al.Circulation Research|October 9, 2010
The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanismMarkus Theurl, Wilfried Schgoer, Karin Albrecht, et al.Circulation|August 25, 2004
Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesisRudolf Kirchmair, Margot Egger, Dirk H Walter, et al.Circulation|February 19, 2004
The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivoRudolf Kirchmair, Roland Gander, Margot Egger, et al.Plos One|January 22, 2010
The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in miceIvan Tancevski, Egon Demetz, Philipp Eller, et al.Pageof 24